From the Department of Social Pediatrics.
Pediatric Intensive Care Unit.
Pediatr Emerg Care. 2020 Jun;36(6):e355-e357. doi: 10.1097/PEC.0000000000001492.
The increase of available synthetic cannabinoids poses an emerging public health threat worldwide. Synthetic cannabinoid use has been mainly reported in adolescent cases in pediatric practices; there are few reported cases involving infants affected by unintentional use. In this case report, we present the youngest age of synthetic cannabinoid bonzai exposure in the literature, discussing a 3-month-old child affected by exposure to the parents' use of bonzai in the home environment. Because unintentional exposure to synthetic cannabinoids like bonzai might be encountered, pediatric emergency teams should be aware of this condition and child protection teams should be informed of suspicions of child negligence and abuse as a part of the medical approach.
越来越多的合成大麻素对全球公共健康构成了新的威胁。在儿科实践中，主要报告了青少年使用合成大麻素的情况；涉及因意外使用而受影响的婴儿的报告很少。在本病例报告中，我们提出了文献中合成大麻素爆竹暴露的最小年龄，讨论了一名 3 个月大的婴儿因父母在家中使用爆竹而受到影响的情况。由于可能会意外接触到像爆竹这样的合成大麻素，儿科急救小组应该意识到这种情况，并且应该将对儿童疏忽和虐待的怀疑告知儿童保护小组，作为医疗方法的一部分。
